InsiderDB

Lobbying disclosures · Lobbying report

SOLV: third_quarter 2026 lobbying report

-Issues related to regulation of Ethylene Oxide (EtO). -Issues related to access to sterilization capacity for medical technologies. -Medicare and Medicaid payment quality programs and policies, including healthcare associated complications, readmissions, payment bundling, potentially avoidable events, quality outcomes, transparency, telehealth, health equity, social determinants of health, maternal mortality, risk adjustment, Medicare Advantage, value-based payment policies, and Medicare and Medicaid data. -VA provider coding system modernization. -Implementation of the Patient Protection and

Follow SOLV
Became public
Oct 20, 2026, 10:48 PM EDT
Event / period date
Not stated
Collected
Nov 12, 2026, 12:57 AM EST

Why this is connected

Legal-name match: SOLVENTUM CORPORATION is Solventum Corp (https://www.sec.gov/Archives/edgar/data/1964738/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).

Reported lobbying amounts

Expenses: $130,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/7a23ccf5-867f-4eed-b231-218dc3e95416/","filing_uuid":"7a23ccf5-867f-4eed-b231-218dc3e95416","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/7a23ccf5-867f-4eed-b231-218dc3e95416/print/","filing_document_content_type":"text/html","income":null,"expenses":"130000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jennifer Nieto","dt_posted":"2026-10-20T22:48:48-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2510 Conway Ave","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"E Maplewood","registrant_state":"MN","registrant_zip":"55144","registrant":{"id":401104406,"url":"https://lda.gov/api/v1/registrants/401104406/","house_registrant_id":null,"name":"SOLVENTUM CORPORATION","description":"Healthcare","address_1":"575 MURRAY BLVD","address_2":null,"address_3":null,"address_4":null,"city":"MURRAY","state":"UT","state_display":"Utah","zip":"84123","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JENNIFER NIETO","contact_telephone":"+1 771-233-8903","dt_updated":"2026-07-27T17:28:39.598359-04:00"},"client":{"id":201690,"url":"https://lda.gov/api/v1/clients/201690/","client_id":12,"name":"SOLVENTUM CORPORATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"UT","state_display":"Utah","country":"US","country_display":"United States of America","ppb_state":"UT","ppb_state_display":"Utah","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-03-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"-Issues related to regulation of Ethylene Oxide (EtO). -Issues related to access to sterilization capacity for medical technologies. -Medicare and Medicaid payment quality programs and policies, including healthcare associated complications, readmissions, payment bundling, potentially avoidable events, quality outcomes, transparency, telehealth, health equity, social determinants of health, maternal mortality, risk adjustment, Medicare Advantage, value-based payment policies, and Medicare and Medicaid data. -VA provider coding system modernization. -Implementation of the Patient Protection and Affordable Care Act (PL 111-148). -Implementation of the Helping Hospitals Improve Patient Care Act. -Implementation of the 21st Century Cures Act (PL 114-255). -Issues related to the use of Artificial Intelligence. -Issues related to H.R. 1 implementation (One Big Beautiful Bill). -Issues related to CY 2026 Home Health Prospective Payment System (HH PPS) Rate Update and DMEPOS. -Issues related to CY 2027 Outpatient Prospective Payment System Rule Update for Skin Substitutes. -Issues related to MDUFA reauthorization.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151133,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"NIETO","last_name":"CAREY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151836,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"-Medicare and Medicaid payment quality programs and policies, including healthcare associated complications, readmissions, payment bundling, potentially avoidable events, quality outcomes, transparency, telehealth, health equity, social determinants of health, maternal mortality, risk adjustment, Medicare Advantage, value-based payment policies, and Medicare and Medicaid data. -VA provider coding system modernization. -Implementation of the Patient Protection and Affordable Care Act (PL 111-148). -Implementation of the Helping Hospitals Improve Patient Care Act. -Implementation of the 21st Century Cures Act (PL 114-255). -Issues related to the use of Artificial Intelligence. -Issues related to H.R. 1 implementation (One Big Beautiful Bill). -Issues related to CY 2026 Home Health Prospective Payment System (HH PPS) Rate Update and DMEPOS. -Issues related to CY 2027 Outpatient Prospective Payment System Rate Update for Skin Substitutes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151133,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"NIETO","last_name":"CAREY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151836,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"-Issues related to Department of Defense policy, procurement, and contracting processes for medical technology. -Issues related to H.R. 1 implementation (One Big Beautiful Bill).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151133,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"NIETO","last_name":"CAREY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151836,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"-Issues related to domestic and global medical supply chain resilience. -Tariff issues generally. -Issues related to the 232 investigation of imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices. -Issues related to Section 301 Investigations of Acts, Policies, and Practices of Various Economies Related to the Failure to Impose and Effectively Enforce a Prohibition on the Importation of Goods Produced with Forced Labor.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151133,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"NIETO","last_name":"CAREY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151836,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to Veterans Administration and Veterans Health Administration policy, procurement, and contracting processes for medical technology.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151133,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"NIETO","last_name":"CAREY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151836,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"JACKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in SOLV

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.